Both in Pharmaceuticals
Briacell Therapeutics vs NextCure
Over the past year BCTX returned −73.8% and NXTC returned −38.7%; their daily moves had a correlation of 0.04.
BCTX −73.8% NXTC −38.7%Growth of $1, one year, split-adjusted
| Metric | BCTX | NXTC |
|---|---|---|
| Price | $3.50 | $6.34 |
| Market cap | $30.4M | $29.0M |
| Today | −1.69% | +10.94% |
| 1 month | −14.2% | +30.9% |
| 6 months | −12.9% | −29.1% |
| Year to date | −50.8% | −55.3% |
| 1 year | −73.9% | −31.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.5M | $20.1M |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | 115.9% |
| Short % of float | 9.3% | 8.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).